| 10 |
SEARCH trial |
|
Jan. 07. 09 |
| 9 |
The Impact of Hypertriglyceridemia on Clinical Outcome of Patients Subjected to Percutaneous Coronary Intervention in the Presence of High and Low High-density Lipoprotein Cholesterol |
|
Jan. 07. 09 |
| 8 |
Emerging Type 2 Diabetes Therapies: Potential of the New DPP-4 Inhibitors |
Ki Hoon Han |
Nov. 23. 07 |
| 7 |
Optimizing the Treatment for Hypertensive Patients Led by Evidence: Is It All about Blood Pressure? |
Jeong Bae Park |
Nov. 09. 07 |
| 6 |
Medical Treatment for Patients with Post-Myocardial Infarction - Importance of Angiotensin Receptor Blockers |
Yuji Ikari |
Nov. 10. 06 |
| 5 |
Medical Environment Post-PCI |
Jean Fajadet |
Oct. 27. 06 |
| 4 |
Preventative Effects of Rosiglitazone on Restenosis after Coronary Stent Implantation |
Donghoon Choi |
Sep. 23. 05 |
| 3 |
The Promise of the Thiazolidinediones in the Management of Type 2 Diabetes-Associated Cardiovascular Disease |
Stephen Alistair Smith |
Sep. 23. 05 |
| 2 |
Mechanisms Linking Angiotensin II & Atherogenesis |
Carlos M. Ferrario |
Sep. 23. 05 |
| 1 |
PPAR-r Agonist and In-stent Restenosis |
Yangsoo Jang |
Jan. 14. 05 |
